Zheng Xu Bin
FDA import alert and refusal historyGuangzhou, ChinaFEI 3012746998
As of October 26, 2026, Zheng Xu Bin (Guangzhou, China) is on the red list of FDA Import Alert 54-16 (Foods/supplements with active pharmaceutical ingredient) for botanical slimming gold version, published by FDA on November 10, 2016, and has no FDA import refusals recorded since October 2016.
Data from FDA public records, last checked . Request a correction
Current status
- Import alerts
- IA 54-16 · red list
- Last import refusal
- None since October 2016
- Last warning letter
- None found
- Last inspection
- None on record
Every FDA record for Zheng Xu Bin
1 record, newest first. Each line links to the FDA page it came from.
2016
- Import alert listingListed on Import Alert 54-16red listBotanical Slimming Gold VersionSource
Questions about Zheng Xu Bin
- Is Zheng Xu Bin on an FDA import alert?
- Yes. As of October 26, 2026, Zheng Xu Bin is on the red list of FDA Import Alert 54-16, “Foods/supplements with active pharmaceutical ingredient”, for botanical slimming gold version; FDA published the listing on November 10, 2016.
- Has FDA refused shipments from Zheng Xu Bin?
- No FDA import refusals for Zheng Xu Bin appear in FDA's refusal data since October 2016, as of October 26, 2026.
- What is Zheng Xu Bin's FEI number?
- Zheng Xu Bin's FDA Establishment Identifier (FEI) is 3012746998.
- Can shipments from Zheng Xu Bin still enter the U.S.?
- Shipments of botanical slimming gold version from Zheng Xu Bin can be detained without physical examination under Import Alert 54-16; FDA releases them only if evidence shows they do not have the listed violation. Importers must consider this listing in their FSVP evaluation (21 CFR 1.505).
Buying from Zheng Xu Bin?
Watch it and get the FDA record the day it changes. Free for one supplier.
SupplierRadar is not affiliated with the U.S. Food and Drug Administration. Data comes from public FDA records and may contain errors. This is not legal advice; importers remain responsible for their supplier evaluations.